InvestSMART

RocketDNA Ltd (ASX:RKT)

ALERT: Price-sensitive ASX Announcement for RKT
Current share price for RKT : $0.022 0 (0%)+
Announcement
Release
19 Aug 2026 7:56AM
Price at Release
$0.022
Full Release
download
Summary
The half-year financial report for RocketDNA Ltd as of 30 June 2026 presents a consolidated net loss after tax of $1,435,401, compared to $1,254,917 for the same period in 2025. The company's revenue increased to $4,997,631 from $3,326,235 in 2025, with Australia and Africa being the main geographical segments contributing to this revenue. Despite the revenue growth, the company reported an overall comprehensive loss of $1,563,251. The net assets decreased to $6,161,013 from $7,605,863, and the company maintained cash and cash equivalents of $2,697,635 at the end of the financial half-year. The financial report indicates challenges in controlling operating expenses and managing foreign currency translation losses. The issuance of additional shares and the acquisition of the remaining non-controlling interest in RocketDNA (WA) Pty Ltd are highlighted as significant equity transactions in the period.
Key Points
  • RocketDNA Ltd reported a net loss after tax of $1,435,401 for the half-year ended 30 June 2026.
  • Revenue increased to $4,997,631, primarily from Australia and Africa segments.
  • Comprehensive loss totaled $1,563,251, reflecting challenges in managing expenses.
  • Net assets decreased to $6,161,013 as of 30 June 2026.
  • Cash and cash equivalents at the end of the period were $2,697,635.
  • Significant equity transactions included the issuance of new shares and acquisition of RocketDNA (WA) Pty Ltd's non-controlling interest.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.